Clinical Trials Browser

Phase 1/2 × Stomach Neoplasms × atezolizumab × Clear all

NCT04166721 2025-04-06

WaKING: Wnt and checKpoint INhibition in Gastric Cancer

Phase 1/2 Active not recruiting

Gastrointestinal

Esophageal Neoplasms, Stomach Neoplasms

NCT06090318 2023-10-19

Milademetan in Combination With Atezolizumab in Patients With Advanced Solid Tumors With CDKN2A Loss

Phase 1/2 Withdrawn

DermatologicGastrointestinalGenitourinaryHead & NeckOther solid neoplasmThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Renal Cell, Melanoma, Mesothelioma, Stomach Neoplasms